Hyundai Hope On Wheels To Award $13.2 Million New Pediatric Cancer Grants During Childhood Cancer Awareness Month

Hyundai Hope On Wheels® (HHOW), a 501(c)(3) nonprofit organization, supported by Hyundai Motor America and its U.S. dealers, continues its fight against pediatric cancer and announces plans for Childhood Cancer Awareness month. For September, the non-profit organization has selected 52 new grant winners to receive a combined $13.2 million for pediatric cancer research. In addition to grants announced earlier this year, this brings the Hyundai Hope On Wheels donations to pediatric cancer research to just over $160 million in the United States, since 1998.  The September campaign theme for the 10th year…

Read More

Hyundai Hope On Wheels Announces Partnership With WWE® In Support Of National Childhood Cancer Awareness Month

To highlight its 20th anniversary, Hyundai Hope On Wheels® (HHOW), a 501c(3) non-profit organization, today announced a partnership with WWE in support of National Childhood Cancer Awareness Month. This week’s Monday Night Raw® kicked off a month-long worth of activities as HHOW joins WWE in a four-city tour to offer children cancer fighters at HHOW partner pediatric institutions a “VIP & Super Fan Experience.” The exclusive fanfare package comes complete with special VIP seating, WWE backstage access, along with a private meet and greet with WWE Superstars and Hope on…

Read More

Hyundai Hope On Wheels Celebrates 20 Years Of Saving Lives And Creating Hope With Resolute Support To End Childhood Cancer

In its newest rounds of grants marking its 20th anniversary, Hyundai Hope On Wheels® (HHOW), a California based 501c(3) non-profit organization announces its support for national Childhood Cancer Awareness Month. The annual September campaign is called “Every Handprint Tells A Story.” A total of 38 doctor-researchers will receive a combined $14.1 million to support novel therapeutic approaches and innovative research options in pediatric cancer. Childhood cancer researchers depend largely on private funding for groundbreaking therapies to get off the ground and to advance treatment approaches to the next phase of…

Read More